| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 22 | 40 | +1,52 % | ||
| AP MOELLER-MAERSK | 9 | 23 | +7,56 % | ||
| VESTAS WIND SYSTEMS | 4 | 9 | +0,79 % | ||
| BAVARIAN NORDIC | 3 | 7 | -1,60 % | ||
| JYSKE BANK | 3 | 3 | -1,98 % | ||
| GENMAB | 3 | - | +1,21 % | ||
| DANSKE BANK | 2 | 10 | -1,59 % | ||
| ISS | 2 | 1 | -1,20 % | ||
| TRYG | 2 | - | +0,77 % | ||
| ORSTED | 1 | 17 | -0,10 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Regulatory tracker: Novo Nordisk, BioMarin gain FDA label expansions | 14 | FiercePharma | ||
| Mo | Vestas finishes SunZia installation in New Mexico | 5 | reNews | ||
| Mo | Danske Bank scales alternatives mandate to $245m with Danish Industry | 3 | Private Equity Insights | ||
| Mo | Why I'm Not Worried About Novo Nordisk Stock | 116 | The Motley Fool | ||
| Mo | Novo Nordisk downgraded at Goldman Sachs on disappointing CagriSema data | 46 | Seeking Alpha | ||
| Mo | ISS A/S: Vesting of Performance Share Units and Restricted Share Units and delivery of ISS shares on 1 March 2026 | 5 | GlobeNewswire (USA) | ||
| Mo | AL Sydbank A/S: Transactions with shares in AL Sydbank by managers and closely associated persons | 3 | GlobeNewswire (USA) | ||
| Mo | Election of employee representatives to the Board of Directors of Novo Nordisk A/S | 409 | GlobeNewswire (Europe) | Bagsværd, Denmark, 2 March 2026 - The employees in Novo Nordisk A/S have completed the election of employee representatives to the Board of Directors of Novo Nordisk A/S.
The following employee... ► Artikel lesen | |
| Mo | Bavarian Nordic CEO to follow board chair out the door after failed private equity takeover | 3 | FiercePharma | ||
| Mo | Eilmeldung am Abend: NOVO NORDISK A/S kippt leicht - was nun? | 30 | Maximilian Berger | ||
| Mo | Konflikt im Nahen Osten: DSV warnt vor Störungen in Lieferketten | 6 | RETAIL-NEWS Deutschland | ||
| Mo | Novo Nordisk: Analyst senkt Kursziel um 35 Prozent - dieser Support muss jetzt halten | 692 | Der Aktionär | Kräftig im Minus ist die Aktie von Novo Nordisk heute in den Handel gestartet. Neben der allgemeinen Marktschwäche sorgte insbesondere eine Abstufung aus den USA für ordentlich Druck. Positiv wurde... ► Artikel lesen | |
| Mo | Genmab A/S: Transactions in Connection with Share Buy-back Program | 2 | GlobeNewswire (USA) | ||
| Mo | Novo Nordisk To Invest €432 Million In Ireland Facility To Expand Oral GLP-1 Production | 16 | RTTNews | ||
| Mo | BARCLAYS stuft Moller-Maersk auf 'Underweight' | 579 | dpa-AFX-Analyser | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für A.P. Moller-Maersk mit einem Kursziel von 11000 dänischen Kronen auf "Underweight" belassen. Die Spannungen im... ► Artikel lesen | |
| Mo | Tryg A/S: Reporting of granting of Tryg shares by senior management | 3 | GlobeNewswire (USA) | ||
| Mo | Is Novo Nordisk's GLP-1 Dominance Fading After Lilly's Clinical Wins? | 31 | Zacks | ||
| Mo | Novo Nordisk: Goldman zieht den Stecker | 98 | Investing.com Deutsch | ||
| Mo | This Novo Nordisk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday | 28 | Benzinga.com | ||
| Mo | Novo Nordisk plans €432m investment in Irish GLP-1 plant | 10 | pharmaphorum |